Saturday 4 July 2020
Home      All news      Contact us     
maverick - 1 month ago

COVID-19: India approves Gilead’s remdesivir to treat severe COVID-19 cases

BENGALURU, June 3 (Reuters) - India s government has approved Gilead Sciences Inc s antiviral drug remdesivir for emergency use for five doses in treating COVID-19 patients.


Latest News
Hashtags:   

COVID

 | 

India

 | 

approves

 | 

Gilead

 | 

remdesivir

 | 

treat

 | 

severe

 | 

COVID

 | 

cases

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources